Flockerzi V, Biel M
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):1023-1026.
PMID: 39570384
DOI: 10.1007/s00210-024-03624-4.
Wittenborn E, Thomas W, Houghton K, Wirachman E, Wu Y, Marletta M
Biochemistry. 2023; 62(10):1568-1576.
PMID: 37129924
PMC: 10686098.
DOI: 10.1021/acs.biochem.3c00052.
Sharina I, Martin E
Cells. 2023; 12(3).
PMID: 36766813
PMC: 9914232.
DOI: 10.3390/cells12030471.
Williams D, Nesbitt N, Muralidharan S, Hossain S, Boon E
Biochemistry. 2023; 62(4):912-922.
PMID: 36746768
PMC: 10332389.
DOI: 10.1021/acs.biochem.2c00639.
Wittenborn E, Marletta M
Int J Mol Sci. 2021; 22(11).
PMID: 34064029
PMC: 8196705.
DOI: 10.3390/ijms22115439.
Meeting report of the 8 International Conference on cGMP "cGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017.
Friebe A, Sandner P, Schmidtko A
Naunyn Schmiedebergs Arch Pharmacol. 2017; 390(12):1177-1188.
PMID: 29018913
PMC: 5783999.
DOI: 10.1007/s00210-017-1429-5.
Receptor Guanylyl Cyclases in Sensory Processing.
Maruyama I
Front Endocrinol (Lausanne). 2017; 7:173.
PMID: 28123378
PMC: 5225109.
DOI: 10.3389/fendo.2016.00173.
Regulation of 5-oxo-ETE synthesis by nitric oxide in human polymorphonuclear leucocytes upon their interaction with zymosan and Salmonella typhimurium.
Viryasova G, Galkina S, Gaponova T, Romanova J, Sudina G
Biosci Rep. 2014; 34(3).
PMID: 24712762
PMC: 4031671.
DOI: 10.1042/BSR20130136.
NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
Bice J, Keim Y, Stasch J, Baxter G
Cardiovasc Res. 2013; 101(2):220-8.
PMID: 24259501
PMC: 3896250.
DOI: 10.1093/cvr/cvt257.
Oxygen mediates vascular smooth muscle relaxation in hypoxia.
Dada J, Pinder A, Lang D, James P
PLoS One. 2013; 8(2):e57162.
PMID: 23451175
PMC: 3579807.
DOI: 10.1371/journal.pone.0057162.
Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.
Miller T, Isenberg J, Roberts D
Br J Pharmacol. 2010; 159(7):1542-7.
PMID: 20233213
PMC: 2850410.
DOI: 10.1111/j.1476-5381.2009.00631.x.
A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases.
Kots A, Martin E, Sharina I, Murad F
Handb Exp Pharmacol. 2008; (191):1-14.
PMID: 19089322
PMC: 3932363.
DOI: 10.1007/978-3-540-68964-5_1.
Effects of nitroglycerin/L-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation.
Gorren A, Russwurm M, Kollau A, Koesling D, Schmidt K, Mayer B
Biochem J. 2005; 390(Pt 2):625-31.
PMID: 15907191
PMC: 1198942.
DOI: 10.1042/BJ20050565.
Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide.
Kollau A, Hofer A, Russwurm M, Koesling D, Keung W, Schmidt K
Biochem J. 2004; 385(Pt 3):769-77.
PMID: 15377279
PMC: 1134753.
DOI: 10.1042/BJ20041354.
A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.
Martin E, Sharina I, Kots A, Murad F
Proc Natl Acad Sci U S A. 2003; 100(16):9208-13.
PMID: 12883009
PMC: 170897.
DOI: 10.1073/pnas.1633590100.
Ancient conserved domains shared by animal soluble guanylyl cyclases and bacterial signaling proteins.
Iyer L, Anantharaman V, Aravind L
BMC Genomics. 2003; 4(1):5.
PMID: 12590654
PMC: 149354.
DOI: 10.1186/1471-2164-4-5.
Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect.
Ballou D, Zhao Y, Brandish P, Marletta M
Proc Natl Acad Sci U S A. 2002; 99(19):12097-101.
PMID: 12209005
PMC: 129404.
DOI: 10.1073/pnas.192209799.
The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.
Bellamy T, Garthwaite J
Mol Cell Biochem. 2002; 230(1-2):165-76.
PMID: 11952092
Isoforms of NO-sensitive guanylyl cyclase.
Russwurm M, Koesling D
Mol Cell Biochem. 2002; 230(1-2):159-64.
PMID: 11952091
NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272.
Becker E, Apeler H, Gerzer R, Minuth T, Pleiss U, Schmidt P
BMC Pharmacol. 2002; 1:13.
PMID: 11801189
PMC: 64637.
DOI: 10.1186/1471-2210-1-13.
